Junctional rhythm is a cardiac rhythm originating from the AV junction (AV node or proximal His bundle) that serves as an escape pacemaker when the sinus node fails to generate impulses or when conduction from the atria is blocked. [1-2] It is classified by rate into junctional escape rhythm (40–60 bpm), accelerated junctional rhythm (60–100 bpm), and junctional tachycardia (>100 bpm). [1][3] The clinical significance depends heavily on the underlying etiology — treatment centers on identifying and correcting the cause rather than the rhythm itself. [3-4]
The following figure illustrates the three P-wave presentations of junctional rhythm — absent, buried in the QRS, and retrograde inverted P waves after the QRS:
1. History
- Onset and duration: Acute vs. chronic; episodic vs. persistent
- Symptoms: Lightheadedness, dizziness, presyncope, syncope, fatigue, exercise intolerance, palpitations, dyspnea
- Timing: Relationship to exertion, sleep, meals, or position changes
- Medication changes: Recent initiation, dose adjustment, or discontinuation of cardiac medications (especially digoxin, beta-blockers, calcium channel blockers, amiodarone)
- Cardiac history: Prior MI, cardiac surgery, catheter ablation (especially AVNRT ablation — transient junctional rhythm is common post-slow-pathway ablation) [3]
- Important negatives: Chest pain, dyspnea at rest, witnessed seizure activity, tongue biting
2. Alarm Features
- Hemodynamic instability: Hypotension, altered mental status, signs of shock
- Syncope or near-syncope — may indicate underlying complete heart block with junctional escape [2][6]
- Very slow escape rate (<40 bpm) — suggests infranodal escape and higher risk [7]
- Wide QRS complex — implies escape below the His bundle (ventricular escape), not true junctional rhythm; higher risk of asystole [2]
- Associated ventricular arrhythmias — particularly in the setting of digoxin toxicity [3]
- Cannon A waves on JVP — retrograde atrial contraction against closed AV valves, causing "pacemaker syndrome"-like symptoms [4]
- Acute MI presentation — junctional rhythm may be a marker of inferior MI with AV nodal ischemia [3]
3. Medications
Common causative medications
- Digoxin — the most classic cause of accelerated junctional rhythm/nonparoxysmal junctional tachycardia; may present with AV dissociation and Wenckebach block [3-4]
- Beta-blockers and calcium channel blockers (diltiazem, verapamil) — suppress sinus node, allowing junctional escape
- Amiodarone, clonidine, lithium
Acute treatment medications (for junctional tachycardia)
- IV beta-blockers (propranolol) — Class IIa per ACC/AHA/HRS [1][3]
- IV diltiazem, procainamide, or verapamil — Class IIa if beta-blockers ineffective [1][3]
- Atropine 0.5–1 mg IV — for symptomatic junctional bradycardia; enhances AV nodal automaticity. Use judiciously if wide QRS (unlikely to help infranodal block) [2][8]
Contraindicated/caution
- Avoid additional AV nodal blocking agents if the junctional rhythm is an escape rhythm (could precipitate asystole)
- Digoxin is not well established for chronic therapy of junctional tachycardia [1]
4. Diet
- Electrolyte-rich diet — hypokalemia and hypomagnesemia can exacerbate junctional rhythms, particularly in the setting of digoxin use [4]
- Ensure adequate hydration — dehydration can worsen bradycardia-related symptoms
- Caffeine — generally not a significant trigger for junctional rhythms, but excessive intake may exacerbate palpitations
5. Review of Systems
- Cardiovascular: Chest pain, palpitations, dyspnea on exertion, orthopnea, edema, syncope
- Neurologic: Dizziness, lightheadedness, confusion, visual changes (digoxin toxicity: xanthopsia)
- GI: Nausea, anorexia, vomiting (digoxin toxicity)
- Endocrine: Cold intolerance, weight gain (hypothyroidism as cause of bradycardia)
- Pulmonary: Cough, wheezing, hypoxia (COPD with hypoxia as associated condition) [4]
6. Collateral History and Family History
- Medication list verification — confirm digoxin dose, recent changes, renal function affecting drug clearance
- Baseline heart rate — athletes may have physiologic junctional rhythm at rest
- Family history: Congenital heart block, channelopathies (e.g., catecholaminergic polymorphic VT has been associated with sinus node dysfunction and junctional rhythm) [9]
- Recent procedures: Cardiac surgery, catheter ablation [3][10]
7. Risk Factors
- Digoxin use (especially with renal insufficiency or hypokalemia) [3-4]
- Acute inferior MI — AV nodal artery ischemia [3]
- Post-cardiac surgery (especially congenital heart disease repair in children) [1]
- Post-catheter ablation (AV node ablation, slow-pathway ablation) [3][10]
- Sinus node dysfunction / sick sinus syndrome [2][4]
- Increased vagal tone (athletes, sleep, vasovagal episodes)
- Electrolyte abnormalities: Hyperkalemia, hypokalemia [4][11]
- Myocarditis, inflammatory conditions [4]
- Hypothyroidism, hypothermia, hypoxia
8. Differential Diagnosis
- Sinus bradycardia — P waves present, upright in II/III/aVF; distinguish from absent/retrograde P waves in junctional rhythm [12]
- Complete (third-degree) AV block with junctional escape — P waves present but dissociated from QRS; atrial rate > ventricular rate [2][6]
- Atrial fibrillation with slow ventricular response — irregularly irregular (vs. regular junctional rhythm); if regular and slow, consider AF with complete heart block and junctional escape [2]
- Isorhythmic AV dissociation — sinus rate and junctional rate nearly identical; P waves "march through" QRS complexes [1-2]
- AVNRT/AVRT — reentrant SVTs often misclassified as junctional tachycardia due to absent visible P waves; AV dissociation, if present, excludes AVRT and makes AVNRT unlikely [1]
- Multifocal atrial tachycardia (MAT) — irregular junctional tachycardia may mimic MAT [1]
- Idioventricular rhythm — wide QRS, rate 20–40 bpm; ventricular origin, not junctional [12]
9. Past Medical History
- Prior MI (especially inferior)
- Cardiac surgery or catheter ablation history
- Sinus node dysfunction / prior pacemaker
- Heart failure — junctional tachycardia can cause tachycardia-mediated cardiomyopathy if incessant [1]
- Renal insufficiency — affects digoxin clearance
- Thyroid disease
- Congenital heart disease
10. Physical Exam
Vital signs
- Heart rate: Typically 40–60 bpm (escape), 60–100 (accelerated), or >100 (tachycardia)
- Blood pressure: May be low if loss of AV synchrony or slow rate
Key findings
- Regular rhythm on auscultation (usually)
- Cannon A waves in JVP — pathognomonic for AV dissociation; atrial contraction against closed tricuspid valve [4]
- Variable S1 intensity — if AV dissociation present
- Signs of heart failure: Elevated JVP, pulmonary crackles, peripheral edema (if chronic or incessant)
- Signs of underlying cause: Thyroid exam, signs of digoxin toxicity (visual changes, GI symptoms)
11. Lab Studies
- Digoxin level — if on digoxin; therapeutic range 0.5–2.0 ng/mL, toxicity more likely >2.0 ng/mL
- Basic metabolic panel: Potassium, magnesium, calcium, creatinine/BUN (electrolyte abnormalities, renal function) [4][11]
- TSH — hypothyroidism as reversible cause
- Troponin — rule out acute MI as underlying etiology [3]
- BNP/NT-proBNP — if concern for heart failure
12. Imaging
- Echocardiogram — assess structural heart disease, LV function, valvular disease; important if junctional rhythm is persistent or unexplained
- Chest X-ray — evaluate for cardiomegaly, pulmonary congestion
- Coronary angiography — if acute MI suspected as the cause
- Imaging is not urgently needed for transient, asymptomatic junctional rhythm with a clear reversible cause (e.g., post-ablation, medication effect)
13. Special Tests
- Continuous telemetry monitoring — essential in the ED to assess rate stability, pauses, and response to interventions
- Ambulatory ECG monitoring (Holter/event monitor) — for outpatient evaluation of intermittent junctional rhythm [2]
- Electrophysiology study (EPS) — rarely needed; may help differentiate focal junctional tachycardia from AVNRT/AVRT when diagnosis is uncertain [4]
- Carotid sinus massage — may help differentiate SVT mechanisms (use with caution)
14. ECG
Classic ECG findings of junctional rhythm: [5][12]
- Regular, narrow QRS complex rhythm (unless pre-existing bundle branch block)
- Rate: 40–60 bpm (escape), 60–100 (accelerated), >100 (tachycardia)
- P-wave patterns (3 variants):
- Absent P waves — no retrograde conduction
- Retrograde P waves buried in QRS — subtle distortion of terminal QRS
- Inverted P waves after QRS — retrograde atrial activation (inverted in II, III, aVF)
- Short RP interval (<120 ms) when retrograde P waves are visible
- AV dissociation — P waves at a different rate from QRS; isorhythmic dissociation common in accelerated junctional rhythm [1-2]
Dangerous patterns to recognize
- Wide QRS escape → likely ventricular, not junctional → higher risk
- Regularized ventricular response in AF → suspect complete heart block with junctional escape [2]
- Bidirectional tachycardia → digoxin toxicity until proven otherwise
15. Assessment
Junctional escape rhythm (40–60 bpm) is a physiologic backup mechanism when the sinus node fails — it is protective, not pathologic in itself. The clinical significance lies in the underlying cause. [3-4]
Accelerated junctional rhythm (60–130 bpm, also called nonparoxysmal junctional tachycardia) is far more common in adults than true junctional tachycardia and is most often due to digoxin toxicity or acute MI. [1][3]
Junctional tachycardia (120–220 bpm) is uncommon in adults and arises from enhanced automaticity. Adults typically have a relatively benign course, whereas children (especially post-cardiac surgery) carry high mortality risk. [1][3]
Complications: Loss of AV synchrony → reduced cardiac output (up to 25% decrease), tachycardia-mediated cardiomyopathy if incessant, and "pacemaker syndrome"-like symptoms from cannon A waves. [4]
16. Treatment Plan
Initial stabilization (symptomatic bradycardia)
- Atropine 0.5–1 mg IV, may repeat q3–5 min (max 3 mg) — enhances AV nodal automaticity [2][8]
- If atropine fails: transcutaneous pacing or dopamine/epinephrine infusion [8][13]
- Do NOT give additional AV nodal blockers if junctional rhythm is an escape rhythm
Treat the underlying cause
- Digoxin toxicity: Hold digoxin; if severe (ventricular arrhythmias, high-grade block), administer digoxin-specific antibody fragments (Digibind/DigiFab) [4]
- Medication-induced: Discontinue or reduce offending agent
- Electrolyte correction: Replete potassium (goal >4.0 mEq/L) and magnesium [4]
- Acute MI: Standard ACS management; inferior MI-related junctional rhythm often resolves spontaneously [3]
Junctional tachycardia (symptomatic, rate >100 bpm)
- IV beta-blockers (propranolol) — Class IIa [1][3]
- IV diltiazem, verapamil, or procainamide — Class IIa if beta-blockers fail [1][3]
- Chronic management: Oral beta-blockers (first-line), oral diltiazem/verapamil, or flecainide/propafenone for refractory cases [3]
- Catheter ablation may be considered for drug-refractory junctional tachycardia (Class IIb) [3]
Permanent pacemaker — indicated when junctional rhythm results from irreversible sinus node dysfunction or complete AV block with symptoms, escape rate <40 bpm, or asystole ≥3 seconds. [7][14] Atrial pacing can be effective for junctional rhythm due to sinus node dysfunction with "pacemaker syndrome"-like symptoms. [4]
The 2018 ACC/AHA/HRS Acute Bradycardia Algorithm provides a structured approach to management:
17. Disposition
Admit/monitor if
- Hemodynamic instability or symptomatic bradycardia
- Suspected acute MI or digoxin toxicity
- New-onset complete heart block with junctional escape
- Need for temporary pacing
- Persistent symptomatic junctional rhythm without clear reversible cause
Observation
Discharge criteria
- Asymptomatic junctional escape rhythm with identified and corrected reversible cause
- Stable hemodynamics, adequate rate, no pauses
- Physiologic junctional rhythm in athletes or during sleep
Specialist consultation triggers
18. Follow Up / Return Precautions
Follow-up timing
- Cardiology follow-up within 1–2 weeks if discharged with new junctional rhythm
- Sooner if medication adjustments were made (e.g., digoxin held)
- Ambulatory ECG monitoring may be arranged for intermittent symptoms
Return precautions — instruct patients to return immediately for:
- Syncope or near-syncope
- Chest pain or shortness of breath
- Severe dizziness or confusion
- Heart rate persistently <40 bpm or new palpitations
Patient counseling
- Explain the rhythm is a "backup pacemaker" and the focus is on treating the cause
- Medication compliance and avoidance of offending drugs
- Expected recovery: Medication-induced junctional rhythm typically resolves within 24–48 hours of drug discontinuation; MI-related junctional rhythm often resolves within days [3]
References
1. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Page RL, Joglar JA, Caldwell MA, et al. Heart Rhythm. 2016.
2. 2018 ACC/AHA/HRS Guideline on The Evaluation and Management Of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Kusumoto FM, Schoenfeld MH, Barrett C, et al. Journal of the American College of Cardiology. 2019.
3. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Page RL, Joglar JA, Caldwell MA, et al. Journal of the American College of Cardiology. 2016.
4. ACC/AHA/ESC Guidelines for the Management of Patients With Supraventricular Arrhythmias--Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias) Developed in Collaboration With NASPE-Heart Rhythm Society. — Blomström-Lundqvist C, Scheinman MM, Aliot EM, et al. Journal of the American College of Cardiology. 2003.
5. Bradycardia. — Korin B. Hudson, J. Aidan Boswick, William J. Brady The Electrocardiagram in Emergency and Acute Care. 2023.
6. Atrioventricular Block With Abnormal P Wave. — Liu JP, Yang JF, Zou T. JAMA Internal Medicine. 2025.
7. 2012 ACCF/AHA/HRS Focused Update Incorporated Into the ACCF/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. — Epstein AE, DiMarco JP, Ellenbogen KA, et al. Journal of the American College of Cardiology. 2013.
8. Part 3: Adult Basic and Advanced Life Support: 2020 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. — Panchal AR, Bartos JA, Cabañas JG, et al. Circulation. 2020.
9. Catecholaminergic Polymorphic Ventricular Tachycardia Associated With Sinus Node Dysfunction and Junctional Rhythm: Case Report and Literature Review. — Brunetti ND, Pellegrino PL, D'Arienzo G, et al. Journal of Electrocardiology. 2016.
10. Characterization of Junctional Rhythm After Atrioventricular Node Ablation. — Alison JF, Yeung-Lai-Wah JA, Schulzer M, Kerr CR. Circulation. 1995.
11. Reversible Junctional Bigeminy in Severe Hyperkalemia: Electrocardiographic and Biochemical Correlation: A Case Report. — Kooner A, Luong R, Kioka M. Medicine. 2025.
12. Electrocardiographic Differential Diagnosis of Bradyarrhythmia. — Megan Starling, William J. Brady The Electrocardiagram in Emergency and Acute Care. 2023.
13. Part 9: Adult Advanced Life Support: 2025 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. — Wigginton JG, Agarwal S, Bartos JA, et al. Circulation. 2025.
14. 2018 ACC/AHA/HRS Guideline on The evaluation and Management Of patients With Bradycardia and Cardiac conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. — Writing Committee Members, Kusumoto FM, Schoenfeld MH, et al. Heart Rhythm. 2019.
15. 2018 ACC/AHA/HRS Guideline on The Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines, and the Heart Rhythm Society. — Kusumoto FM, Schoenfeld MH, Barrett C, et al. Journal of the American College of Cardiology. 2019.